Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025
Same author

Health related quality of life and perceived social support in French and Lebanese MS patients: A comparative study.

Multiple sclerosis and related disorders·2022
Same author

Does post dural puncture headache exist in idiopathic intracranial hypertension? A pilot study.

Revue neurologique·2020
Same author

MRI characteristics of MOG-Ab associated disease in adults: An update.

Revue neurologique·2020
Same author

Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients.

European journal of neurology·2019
Same author

Acute idiopathic optic neuritis: not always benign.

European journal of neurology·2018
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Recommendations for useful serum testing with suspected multiple sclerosis.

J-C Ouallet1, E Bodiguel, C Bensa

  • 1Inserm U 1049, pôle des neurosciences cliniques, service de neurologie, CHU de Bordeaux Pellegrin Tripode, université de Bordeaux Segalen, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. jean-christophe.ouallet@chu-bordeaux.fr

Revue Neurologique
|February 14, 2012
PubMed
Summary
This summary is machine-generated.

This study provides expert consensus guidelines for serum exams in multiple sclerosis (MS) diagnosis. These recommendations aim to standardize practices where scientific evidence is lacking for MS patient management.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

Related Experiment Videos

Last Updated: May 25, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

Area of Science:

  • Neurology
  • Clinical Diagnostics
  • Medical Guidelines

Background:

  • Numerous clinical questions regarding multiple sclerosis (MS) management lack definitive answers in scientific literature.
  • Clinical decisions for MS patients are frequently individualized, not evidence-based.
  • A need exists for standardized practices in diagnosing and managing MS.

Purpose of the Study:

  • To establish expert consensus guidelines for serum examinations pertinent to the diagnosis of multiple sclerosis.
  • To provide a framework for consistent clinical practices in MS diagnosis.
  • To address the gap in scientific evidence for MS diagnostic procedures.

Main Methods:

  • Formal expert consensus methodology.
  • Systematic literature analysis by a working group, including existing recommendations and original research.
  • Iterative drafting and critical review of guideline proposals by rating and independent reading groups.

Main Results:

  • Development of a consensual document outlining recommendations for serum exams in MS diagnosis.
  • Each recommendation is graded based on the level of scientific proof or degree of expert consensus.
  • Guidelines are presented to support consistent clinical decision-making in MS.

Conclusions:

  • The established guidelines offer a consensus-driven approach to serum diagnostics in multiple sclerosis.
  • These recommendations aim to improve diagnostic consistency and patient care in MS.
  • The guidelines address practical needs in MS management where evidence is limited.